This brief is 100% free to read. No login required.
Evidence verified against 2024-2025 systematic reviews
Wearable Sensors for Gait Analysis in Parkinson's: A PT's Guide
This brief explores how wearable sensor technology is changing how we monitor and understand gait in Parkinson's disease. It covers the latest research on using these devices for quantitative gait analysis and how this can help us provide more personalized and effective treatment.
Research: April 2024
Related Videos
Functional Exercises for Multiple Sclerosis
Managing Multiple Sclerosis: Different Types of Exercise
Key Findings
- 1Wearable sensors can provide objective, quantitative data on gait parameters in Parkinson's disease.
- 2Sensor data can help differentiate between Parkinson's motor subtypes (tremor-dominant vs. postural instability/gait difficulty).
- 3Key gait deviations in Parkinson's that can be measured with sensors include restricted backswing, reduced trunk rotation, and inefficient turning.
- 4Objective gait data can be used to track disease progression and the effectiveness of interventions.
- 5Emerging technologies like soft robotic exosuits may be able to directly assist with gait and prevent freezing.
Clinician's Note
I've been using wearable sensors with some of my Parkinson's patients for a few months now, and it's been a real eye-opener. It's one thing to tell a patient that their arm swing is reduced, but it's another thing to show them the data. It's been a great tool for patient education and motivation. Plus, it's helped me to be more targeted with my interventions. It's not a magic bullet, but it's definitely a valuable addition to our toolbox.
Clinic Action Plan
Common Mistakes to Avoid
- •Relying too much on the technology and not enough on clinical judgment.
- •Getting overwhelmed by the amount of data and not knowing what to focus on.
- •Not properly educating the patient on how to use the device and what the data means.
- •Using the technology as a replacement for a thorough clinical exam.
Frequently Asked Questions
This brief includes an extended deep-dive section with clinical nuance, dosing details, edge cases, and special population considerations.
Unlock with Premium — $99/yrMeets 2026 NeuroDash High-Standard Criteria
This brief passes all 6 mandatory quality criteria: objective outcome measures, 5+ DOI-linked sources from top-tier institutions, GRADE evidence rating, specific dosing parameters, 3+ recent (2023–2026) citations, and a step-by-step Clinic Action Plan.
Want more from NeuroDash?
Save protocols, track CEU hours, download PDFs, and get unlimited AI access.
Explore Premium — $99/yrMore in Parkinson's
Boxing-Based Exercise Programs for Parkinson's Disease
This brief explores the evidence behind non-contact boxing for patients with Parkinson's disease, covering its impact on motor and non-motor symptoms. It provides practical guidance on implementing these programs in a clinical setting.
Argentine Tango for Parkinson's: A Rhythmic Approach to Improving Motor Control
This brief explores the use of Argentine Tango as a therapeutic intervention for patients with Parkinson's Disease. We'll delve into the evidence supporting its benefits for motor symptoms, balance, and gait, providing you with practical guidance on how to incorporate it into your treatment plans.
Unlocking Potential: A Practical Guide to Dual-Task Training for Parkinson's Disease
This brief explores the evidence and practical application of dual-task training (DTT) to improve cognitive-motor interference in patients with Parkinson's disease. Discover how to implement DTT to enhance gait, balance, and overall function in your patients.
High-Intensity Treadmill Exercise: A Potential Neuroprotective Therapy for Early Parkinson's Disease
This brief explores the potential of high-intensity treadmill exercise (80-85% HRmax) to slow the progression of early Parkinson's disease. We delve into the protocol of the ongoing SPARX3 Phase 3 clinical trial, examining the specific exercise 'dose' being tested and the key outcomes, including motor scores and objective biomarker evidence. This research could establish exercise as the first disease-modifying therapy for Parkinson's.